Agios Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-6.44-8.04-26.1325.19
Price/Sales ratio
15.748.905.233.49
Earnings per Share (EPS)
$-5.62$-4.50$-1.38$1.43

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-70.50-20.63-8.22-8.46-7.65-7.22-8.911.23-20.63-3.52-5.18-7.65
Price/Sales ratio
57.7141.1023.3661.9228.0524.2914.71N/A108.0346.2084.4128.05
Price/Book Value ratio
8.887.044.557.093.854.477.481.531.391.521.094.47
Price/Cash Flow ratio
-63.55-31.5742.34-9.33-8.69-7.72-10.28-4.87-4.97-4.18-3.88-8.69
Price/Free Cash Flow ratio
-61.26-25.0256.99-9.18-8.50-7.48-9.78-4.81-4.89-4.17-3.82-8.50
Price/Earnings Growth ratio
1.86-0.21-0.13-0.250.71-0.750.33-0.000.19-0.000.040.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-53.57%-139.90%-215.00%-580.47%98.51%98.88%98.61%N/A88.03%64.56%88.03%98.88%
Operating Profit Margin
-82.82%-200.78%-287.56%-745.84%-384.03%-361.56%-155.58%N/A-2732.07%-1459.51%-2732.07%-361.56%
Pretax Profit Margin
-82.51%-199.14%-283.96%-731.60%-366.60%-348.96%-161.11%N/A-1627.81%-1312.63%-1627.81%-348.96%
Net Profit Margin
-81.86%-199.14%-283.96%-731.60%-366.60%-336.36%-164.97%N/A-523.56%-1312.63%-1627.81%-336.36%
Effective Tax Rate
0.78%0.36%2.87%2.04%-9.50%3.61%-2.39%554.80%67.83%N/AN/A-9.50%
Return on Assets
-10.87%-28.02%-32.05%-51.21%-40.30%-44.52%-39.30%111.61%-6.01%-37.57%-18.71%-40.30%
Return On Equity
-12.60%-34.11%-55.34%-83.79%-50.32%-61.91%-83.90%124.20%-6.77%-43.41%-20.68%-50.32%
Return on Capital Employed
-12.56%-32.32%-37.87%-61.75%-47.38%-53.43%-41.67%-27.46%-33.07%-45.04%-33.07%-47.38%
Liquidity Ratios
Current Ratio
5.886.376.334.686.566.586.74N/AN/AN/A13.296.56
Quick Ratio
5.887.496.696.206.556.506.5817.5113.1611.9812.536.55
Cash ratio
0.227.106.485.988.610.871.353.392.221.292.220.87
Days of Sales Outstanding
70.7471.6143.4131.1440.3747.42N/AN/A56.5438.2356.5440.37
Days of Inventory outstanding
0.00-151.59-53.46-179.34227.042.03K1.91K314.711.81K732.611.81K227.04
Operating Cycle
70.74-79.98-10.04-148.20267.422.07K1.91KN/A1.87K770.841.83K267.42
Days of Payables Outstanding
40.2437.9528.3528.394.67K6.06K2.30K324.623.98K375.593.98K6.06K
Cash Conversion Cycle
30.49-117.93-38.40-176.59-4.40K-3.98K-393.75N/A-2.11K395.24-3.48K-4.40K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.120.12N/AN/A0.070.110.12
Debt Equity Ratio
N/AN/AN/AN/AN/A0.170.26N/AN/A0.080.120.17
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.140.19N/AN/A0.060.060.14
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.150.20N/AN/A0.080.070.15
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-17.72N/AN/AN/A-30.41N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-3.26-2.76N/AN/A-4.11-3.61-3.26
Company Equity Multiplier
1.151.211.721.631.241.392.131.111.121.151.121.39
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.90-1.300.55-6.63-3.22-3.14-1.43N/A-21.73-11.03-21.73-3.14
Free Cash Flow / Operating Cash Flow Ratio
1.031.260.741.011.021.031.051.011.011.001.011.03
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-3.26-2.76N/AN/A-4.11-3.61-3.26
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-53.59-39.23N/AN/A-19.72-22.65-53.59
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A